• Home
  • Store
    • Total Access Subscriptions
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Institutional Site Licenses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Toolkit/AskCarlat AI
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » Keywords » Smoking Cessation

Items Tagged with 'Smoking Cessation'

ARTICLES

Research Update

Higher-Dose NRT May Help Dual Users Quit Both Cigarettes and Vapes

November 1, 2026
Jesse Koskey, MD.
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Reviewed by Jesse Koskey, MD.
Dr. Koskey has no financial relationships with companies related to this material.

Nicotine is one of the most addictive drugs, and standard nicotine replacement therapy (NRT) sometimes isn’t strong enough to help patients stop smoking or vaping.


Read More
Fact Sheet

Cytisinicline (Cytisine) Fact Sheet from Complementary and Alternative Medicine in Psychiatry: A Fact Book (2026)

October 16, 2026
Chris Aiken, MD

Chris Aiken, MD

Dr. Aiken has no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Cytisinicline—historically known as cytisine—is a naturally occurring plant-based alkaloid that has been used for smoking cessation in Central and Eastern Europe since World War II. 




Read More
Fact Sheet

Varenicline (Chantix) Fact Sheet

January 1, 2026
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Varenicline is the most effective tobacco cessation medication.




Read More
Fact Sheet

Nicotine Patch (Nicoderm CQ, others) Fact Sheet

January 1, 2026
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Nicotine patches are a first-line intervention in patients who are able to quit smoking at initiation of treatment and who are regular and constant smokers.




Read More
Fact Sheet

Nicotine Nasal Spray (Nicotrol NS) Fact Sheet

January 1, 2026
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

The idea of nasal administration of nicotine is appealing in that it more closely approximates the time course of plasma nicotine levels observed after cigarette smoking than other dosage forms; however, the high cost and unpleasant side effects make this difficult to recommend as a first-line treatment, especially since no one form of nicotine replacement therapy has been shown to be more effective than another.




Read More
Fact Sheet

Nicotine Inhaled (Nicotrol Inhaler) Fact Sheet

January 1, 2026
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Inhaled nicotine is expensive and can cause unpleasant side effects, both of which make this form of nicotine replacement therapy difficult to recommend as a first-line option since no single therapy has been shown to be more effective than another.




Read More
Fact Sheet

Nicotine Gum/Lozenge (Nicorette, others) Fact Sheet

January 1, 2026
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

First-line intervention for those patients who can stop smoking at initiation of therapy; nicotine in the form of gum or lozenge may act as a substitute oral activity, which may aid in behavior modification.




Read More
Fact Sheet

Bupropion SR (Zyban) Fact Sheet

January 1, 2026
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

DSM-5: “Problematic pattern” of tobacco use leading to “significant distress” that lasts at least 12 months.




Read More
Fact Sheet

Smoking Cessation

January 1, 2026
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

DSM-5: “Problematic pattern” of tobacco use leading to “significant distress” that lasts at least 12 months.




Read More
Try The New AskCarlat AI

Ask any clinical question—our AI responds using only the peer-reviewed, editorially vetted content from Carlat Publishing.

Available In The Carlat Toolkit
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • CAM1e_3DCover_Spiral_sm.png

    Complementary and Alternative Medicine in Psychiatry: A Fact Book (2026) -

    Fact sheets for 67 treatments that fall outside conventional psychopharmacology.
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2205347851.jpg
    General Psychiatry

    Balancing Focus and Cardiovascular Risk with ADHD Treatment

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2026 Carlat Publishing, LLC and Affiliates, All Rights Reserved.